Dabigatran to be Assessed in Alzheimer Disease in BEACON Study
January 15th 2019The direct thrombin inhibitor is planned to be evaluated for its effect on the neurodegenerative disease in a trial of 40 to 60 patients with MCI and Alzheimer, led by researchers at the University of Rhode Island.
AHS Releases Position Statement on CGRP Inhibition Integration Into Clinical Practice
January 14th 2019The guidance provided the society’s recommendations for the use of the newly approved calcitonin gene-related peptide monoclonal antibodies for the prevention of migraine, among other guidance points.
Trevor Resnick, MD, on Perampanel for Secondarily Generalized Seizures
January 9th 2019The pediatric epileptologist at Nicklaus Children’s Hospital spoke about the long-term seizure freedom data that showed that perampanel was associated with a sustained or increased improvement in seizure control.
What You Need to Know About Subcutaneous Immunoglobulin for the Treatment of CIDP and PI
January 5th 2019This guide includes everything you need to know about subcutaneous immunoglobulin (Hizentra, CSL Behring) in the treatment of chronic inflammatory demyelinating polyneuropathy as well as primary immunodeficiency.